LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY

被引：2
|
作者：
Mease, P. J. [1 ,2 ]
Setty, A. [3 ]
Papp, K. [4 ]
Van den Bosch, F. [5 ]
Tsuji, S. [6 ]
Keiserman, M. [7 ]
Bu, X. [3 ]
Chen, L. [3 ]
Mccaskill, R. [3 ]
Mcdearmon-Blondell, E. [3 ]
Wung, P. [3 ]
Tillett, W. [8 ]
机构：
[1] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Rheumatol, Seattle, WA 98195 USA
[3] AbbVie Inc, Immunol, N Chicago, IL USA
[4] Papp Clin Res & Prob Med Res, Dermatol, Waterloo, ON, Canada
[5] Univ Ghent, VIB Ctr Inflammat Res, Internal Med & Pediat, Ghent, Belgium
[6] Natl Hosp Org, Osaka Minami Med Ctr, Orthopaed Rheumatol, Osaka, Japan
[7] Pontifical Catholic Univ, Sch Med, Rheumatol, Porto Alegre, RS, Brazil
[8] Royal Natl Hosp Rheumat Dis, Rheumatol, Bath, Avon, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.1897
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1041
引用
收藏
页码：836 / 837
页数：2
相关论文
共 50 条
  • [1] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY
    Mease, Philip J.
    Setty, Arathi
    Papp, Kim
    Van den Bosch, Filip
    Tsuji, Shigeyoshi
    Keiserman, Mauro
    Bu, Xianwei
    Chen, Liang
    Mccaskill, Reva
    Mcdearmon-Blondell, Erin
    Wung, Peter
    Tillett, William
    RHEUMATOLOGY, 2023, 62
  • [2] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 1 STUDY
    Mcinnes, I.
    Kato, K.
    Magrey, M.
    Merola, J. F.
    Kishimoto, M.
    Haaland, D.
    Chen, L.
    Duan, Y.
    Liu, J.
    Lippe, R.
    Wung, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 260 - 261
  • [3] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    McInnes, Iain B.
    Kato, Koji
    Magrey, Marina
    Merola, Joseph F.
    Kishimoto, Mitsumasa
    Haaland, Derek
    Chen, Liang
    Duan, Yuanyuan
    Liu, Jianzhong
    Lippe, Ralph
    Wung, Peter
    RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 275 - 292
  • [4] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    Iain B. McInnes
    Koji Kato
    Marina Magrey
    Joseph F. Merola
    Mitsumasa Kishimoto
    Derek Haaland
    Liang Chen
    Yuanyuan Duan
    Jianzhong Liu
    Ralph Lippe
    Peter Wung
    Rheumatology and Therapy, 2023, 10 : 275 - 292
  • [5] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 1 STUDY
    Mcinnes, I.
    Kato, K.
    Magrey, M.
    Merola, J. F.
    Kishimoto, M.
    Haaland, D.
    Li, Y.
    Liu, Y.
    Liu, J.
    Lippe, R.
    Wung, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1137 - 1138
  • [6] SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGICS: 3-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY
    Mease, P. J.
    Setty, A.
    Papp, K.
    Van den Bosch, F.
    Tsuji, S.
    Keiserman, M.
    Carter, K.
    Mccaskill, R.
    Mcdearmon-Blondell, E.
    Wung, P.
    Tillett, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1136 - 1137
  • [7] Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2
    Mease, Philip J.
    Lertratanakul, Apinya
    Anderson, Jaclyn K.
    Papp, Kim
    Van den Bosch, Filip
    Tsuji, Shigeyoshi
    Dokoupilova, Eva
    Keiserman, Mauro
    Wang, Xin
    Zhong, Sheng
    McCaskill, Reva M.
    Zueger, Patrick
    Pangan, Aileen L.
    Tillett, William
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03) : 312 - 320
  • [8] Long-Term Safety and Effectiveness of Upadacitinib in Patients with Psoriatic Arthritis: Results at 56 Weeks from the SELECT-PsA 1 Study
    McInnes, Iain
    Kato, Koji
    Magrey, Marina
    Merola, Joseph
    Kishimoto, Mitsumasa
    Tena, Cesar Pacheco
    Haaland, Derek
    Chen, Liang
    Duan, Yuanyuan
    Zueger, Patrick
    Liu, Jianzhong
    Lippe, Ralph
    Pangan, Aileen
    Behrens, Frank
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2801 - 2804
  • [9] LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS AT 56 WEEKS FROM THE SELECT-PsA 1 STUDY
    McInnes, I.
    Kato, K.
    Magrey, M.
    Merola, J. F.
    Kishimoto, M.
    Tena, C. F. Pacheco
    Haaland, D.
    Chen, L.
    Duan, Y.
    Zueger, P.
    Liu, J.
    Lippe, R.
    Pangan, A.
    Behrens, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1288 - 1289
  • [10] UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: 56-WEEK DATA FROM THE PHASE 3 SELECT-PSA 2 STUDY
    Mease, P. J.
    Lertratanakul, A.
    Papp, K.
    Van den Bosch, F.
    Tsuji, S.
    Dokoupilova, E.
    Keiserman, M.
    Bu, X.
    Chen, L.
    Mccaskill, R.
    Zueger, P.
    Mcdearmon-Blondell, E.
    Pangan, A.
    Tillett, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 312 - 314
12345